Evommune, Inc. EVMN

$5.99 -11.00% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 PRIMARY DOCUMENT 2026-10-15 View →
8-K 8-K 2026-10-01 View →
8-K 8-K 2026-09-23 View →
8-K 8-K 2026-09-15 View →
8-K 8-K 2026-09-09 View →
10-Q 10-Q 2026-08-06 View →
8-K 8-K 2026-08-06 View →
8-K 8-K 2026-07-30 View →
4 PRIMARY DOCUMENT 2026-07-10 View →
4 PRIMARY DOCUMENT 2026-07-08 View →
8-K 8-K 2026-06-29 View →
4 PRIMARY DOCUMENT 2026-06-24 View →
4 PRIMARY DOCUMENT 2026-06-24 View →
4 PRIMARY DOCUMENT 2026-06-24 View →
4 PRIMARY DOCUMENT 2026-06-03 View →
4 PRIMARY DOCUMENT 2026-06-03 View →
4 PRIMARY DOCUMENT 2026-06-03 View →
4 PRIMARY DOCUMENT 2026-06-03 View →
4 PRIMARY DOCUMENT 2026-06-03 View →
8-K 8-K 2026-06-02 View →
4 PRIMARY DOCUMENT 2026-06-01 View →
4 PRIMARY DOCUMENT 2026-06-01 View →
10-Q 10-Q 2026-05-07 View →
8-K 8-K 2026-05-07 View →
DEF 14A DEF 14A 2026-04-21 View →
4 PRIMARY DOCUMENT 2026-04-17 View →
4 PRIMARY DOCUMENT 2026-04-17 View →
4 PRIMARY DOCUMENT 2026-04-17 View →
4 PRIMARY DOCUMENT 2026-04-17 View →
4 PRIMARY DOCUMENT 2026-04-17 View →
4 PRIMARY DOCUMENT 2026-04-17 View →
S-1 S-1 2026-04-17 View →
8-K 8-K 2026-04-13 View →
10-K 10-K 2026-03-05 View →
8-K 8-K 2026-03-05 View →
4 4 2026-02-19 View →
4 Insider transaction 2026-02-18 View →
4 Insider transaction 2026-02-17 View →
8-K 8-K 2026-02-13 View →
8-K 8-K 2026-02-10 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$5.99
Market Cap
$244.25 million
52-Week Range
$4.94 – $33.20
Average Volume
978K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.